In addition to being burdened with more meetings and work during most new drug reviews, FDA staff also is seeing more applications, which is helping increase user fees.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?